[Prevalence of varicella zoster virus in pregnant patients].
The prevalence of IgG antibodies to varicella-zoster (VZ) virus was estimated by indirect immunofluorescence test in a sero-epidemiological study in 295 healthy pregnant women at the age of 17 to 36 years. 93.2% were considered to be seropositive and consequently protected against varicella. No antibodies to VZ virus were detected in 6.8%. Owing to the lacking protective antibodies the occurrence of maternal varicella has to be taken into account.
Sauerbrei
A
A
Institut für Medizinische Mikrobiologie, Medizinischen Akademie Erfurt.
Sonntag
S
S
Wutzler
P
P
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis*; D000918:Antibody Specificity / Q000276:immunology; D002644:Chickenpox / Q000453:epidemiology* / Q000276:immunology; D003430:Cross-Sectional Studies; D005260:Female; D005455:Fluorescent Antibody Technique; D005859:Germany, East / Q000453:epidemiology; D014645:Herpesvirus 3, Human / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D015994:Incidence; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology* / Q000276:immunology
D000914:Antibodies, Viral; D007074:Immunoglobulin G
Durchseuchung von Schwangeren mit dem Varicella-Zoster-Virus.